• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Feb 26;15(1):6956.
doi: 10.1038/s41598-025-91235-1. Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay

Silpsiri Sinsulpsiri[SUP] 1 [/SUP], Yuji Nishii[SUP] 2 3 [/SUP], Qing-Feng Xu-Xu[SUP] 2 [/SUP], Masahiro Miura[SUP] 2 [/SUP], Patcharin Wilasluck[SUP] 4 5 [/SUP], Kanokwan Salamteh[SUP] 4 5 [/SUP], Peerapon Deetanya[SUP] 4 5 [/SUP], Kittikhun Wangkanont[SUP] 4 5 [/SUP], Aphinya Suroengrit[SUP] 6 [/SUP], Siwaporn Boonyasuppayakorn[SUP] 6 [/SUP], Lian Duan[SUP] 7 8 [/SUP], Ryuhei Harada[SUP] 8 [/SUP], Kowit Hengphasatporn[SUP] 8 [/SUP], Yasuteru Shigeta[SUP] 8 [/SUP], Liyi Shi[SUP] 9 10 [/SUP], Phornphimon Maitarad[SUP] 11 [/SUP], Thanyada Rungrotmongkol[SUP] 12 13 [/SUP]



Affiliations
Abstract

Ebsulfur and ebselen derivatives that were proven to be potent inhibitors against the main protease (M[SUP]Pro[/SUP]) of SARS-CoV-2 which is an essential enzyme for viral replication were chosen to study the quantitative structure-activity relationship (QSAR) analysis using a classical multiple linear regression (MLR) and a machine learning approach of random forest (RF) and artificial neural network (ANN) in order to find the relationship between molecular structural properties and biological inhibitory activities. With the statistical criteria, the R[SUP]2[/SUP] values of MLR, RF, and ANN models for the training set were 0.83, 0.82, and 0.92, respectively. The RMSE values of the test were considered for model evaluation, and the results were 0.27, 0.18, and 0.09 for MLR, RF, and ANN models, respectively. Therefore, the ANN model was the best-obtained model for predicting the M[SUP]Pro[/SUP] inhibitory activity of thirteen new synthetic ebselen analogs that haven't tested the biological assay before. Notably, our predicted inhibitory activities against SARS-CoV-2 were then examined using enzyme-based assays and cytotoxicity tests, which found that compound P8 resulted in a good potential candidate for SARS-CoV-2 M[SUP]Pro[/SUP] inhibitory activity. Furthermore, the molecular dynamics simulations were performed to study the dynamic interaction of ligand and binding site; the results showed a binding pathway and mechanism of compound P8 with key residues surrounding the active site of SARS-CoV-2 M[SUP]Pro[/SUP], which is useful for further development of ebselen derivatives.

Keywords: Ebselen and ebsulfur derivatives; LB-PaCS-MD; Machine learning; QSAR; SARS-CoV-2 inhibitory activity.

 
Back
Top Bottom